Friday - August 23, 2019 Bayer to sell its Animal Health business unit to Elanco for 7.6 billion U.S. dollars Exit of Animal Health business completes the series of portfolio measures initiated by Bayer in November 2018 ahead of announced schedule / Enhances Bayer’s focus as a global leader in life sciences more
Tuesday - July 30, 2019 Bayer on track in operational business Group sales increase by 0.9 percent (Fx & portfolio adj.) to 11.485 billion euros / EBITDA before special items advances by 24.7 percent to 2.927 billion euros / Crop Science sees sales decline (Fx & portfolio adj. and pro forma) in challenging environment but posts substantial earnings growth due to acquired business / Pharmaceuticals posts higher sales and strong earnings growth / Consumer Health increases sales and earnings / Net income falls by 49.1 percent to 404 million euros, held back by special items for restructuring and impairments / Core earnings per share increase by 5.9 percent to 1.62 euros / Group outlook confirmed yet increasingly ambitious more
Wednesday - July 10, 2019 Award winning Bepanthen strikes gold in MadeForMums awards Bayer’s nappy cream recognised as the best by respected online advice website more
Advancing Together: Bayer to Acquire Monsanto The acquisition realizes the joint vision of integrated agricultural offering delivering superior solutions for growers and creates an innovation powerhouse for the next generation of farming. more
